Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

Soliwoda-Doan was one of many Americans who had never even heard of H.B.V. There is no cure for hepatitis B, but it is ...

1 Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, China 2 Department of Clinical Medicine, First College of Clinical Medicine, Binzhou Medical University, Yantai, ...

The company will evaluate the Hepzato kit as a combination therapy with the standard of care in patients with liver-dominant ...

Patients diagnosed with uveal melanoma, which once it has spread to major organs is almost always fatal, can now be offered the first-of-its-kind treatment, tebentafusp, following today’s approval by ...

Patients diagnosed with uveal melanoma, which once it has spread to major organs is almost always fatal, can now be offered the first-of-its-kind treatment, tebentafusp, following today’s ...

Patients with uveal melanoma face many threats: early death, pain, visual handicap, and facial disfigurement, which result in loss of income and independence, with restrictions on occupational ...

Delcath Systems (DCTH) announced that the U.S. Food and Drug Administration FDA has completed its 30-day review of the Company’s ...

Patients diagnosed with uveal melanoma can now be offered the first-of-its-kind treatment, tebentafusp, following today’s approval by the National Institute for Health and Care Excellence (NICE). Over ...

Uveal melanoma is the most common type of eye cancer in adults ... the cancer has grown into tissues around the eye or another part of the body, such as the liver. If your cancer has grown into the ...